Efficacy and safety of radiofrequency ablation through bronchoscopy in the treatment of lung cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037795

Enrollment

Unknown

Registered

2020-09-02

Start date

2020-09-30

Completion date

Unknown

Last updated

2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Case series:Radiofrequency ablation for lung cancer

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years ; 2. The maximum diameter of the tumor 1cm; 5. Able to understand research requirements; 6. Willingness to participate in all aspects of the protocol during the clinical trial, with informed consent signed by the subject or legal representative.

Exclusion criteria

Exclusion criteria: 1. Any contraindications in bronchoscopy; 2. Known clotting disorder or abnormal platelet function or platelet count 2.

Design outcomes

Primary

Measure	Time frame
Imaging changes in ablation zone;	—

Countries

China

Contacts

Public ContactXiaoju Zhang

Henan Provincial People's Hospital

zhangxiaoju1010@henu.edu.cn+86 15837101166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026